Prochlorperazine Maleate Tablets IP – Manufacturer & Exporter India

1. Product Introduction

Prochlorperazine is a phenothiazine medicine with antiemetic and antipsychotic actions. It is used in selected settings for severe nausea and vomiting, and some formulations are authorized for vertigo or psychiatric indications depending on local prescribing information. Healthy Life Pharma Pvt. Ltd. is identified as manufacturer and Healthy Inc as exporter in the supplied information. The listed product is an uncoated 5 mg tablet, not a mouth-dissolving formulation.

2. Product Specifications

3. Manufacturing Technology

For low-strength tablets, validated blending, dosage-unit uniformity and appropriate protection from light and oxidation are important formulation considerations. Manufacturing controls, excipient selection and protective packaging must be based on approved process validation and stability evidence. The submitted composition identifies an uncoated tablet; specialized film coating, yellow-light processing and mouth-dissolving technology are not asserted as capabilities without confirmation.

4. Quality Assurance

Appropriate tests may include identification, assay, uniformity of dosage units, dissolution or disintegration as specified, related substances and stability. Numerical acceptance criteria must follow the applicable current pharmacopoeial monograph and approved registered specification. Actual batch test results and certificates should be requested before procurement.

5. Mechanism and Therapeutic Uses

Prochlorperazine acts primarily as a dopamine D2-receptor antagonist, including at the chemoreceptor trigger zone involved in vomiting. Indications vary with formulation and jurisdiction.

• Severe nausea and vomiting: May be prescribed when an antiemetic is appropriate.
• Vertigo: Some approved formulations are used for dizziness associated with vestibular disorders.
• Psychiatric indications: Antipsychotic use requires indication-specific clinical assessment and dosing.

Not all formulations are interchangeable, and prochlorperazine is not suitable for every cause of vomiting or dizziness.

6. Export and Regulatory Support

For B2B and distributor enquiries, request current product approvals, manufacturing licenses, applicable GMP documentation, approved specifications, batch COA and stability data. CTD/ACTD dossiers, COPP, FSC, packaging configurations, export market registrations and shipping terms are subject to documentary confirmation; no specific certificates or international market approvals are guaranteed here.

7. Frequently Asked Questions

What strength is confirmed in the supplied formulation?

Prochlorperazine Maleate IP 5 mg, in an uncoated tablet. Other strengths and mouth-dissolving variants require separate confirmation.

Does it cause sleepiness?

Yes. Sedation, dizziness and reduced alertness can occur. Avoid driving if affected and avoid alcohol unless a clinician advises otherwise.

Can it treat motion sickness?

It is not necessarily the preferred medicine for motion sickness. Selection depends on the cause, approved indication and clinical guidance.

Who is listed as manufacturer and exporter?

The supplied product information names Healthy Life Pharma Pvt. Ltd. and Healthy Inc, respectively. Credentials and product registration should be verified.

8. Dosage and Administration

Dosage depends on the indication, age, other medical conditions and the approved product label. Use only the prescribed regimen. The supplied 5 mg tablet is intended for oral administration according to the approved label; do not apply mouth-dissolving tablet instructions to this uncoated formulation. Seek medical attention for persistent vomiting, dehydration or severe neurological symptoms.

9. Side Effects and Precautions

• Neurological: Drowsiness, dizziness, acute dystonia, akathisia, tremor and other extrapyramidal effects may occur. Tardive dyskinesia and neuroleptic malignant syndrome are serious risks.
• Cardiovascular: Orthostatic hypotension and QT prolongation or arrhythmia risk may be relevant, especially with interacting medicines.
• Older adults: Antipsychotics carry an increased mortality warning in elderly patients with dementia-related psychosis; not approved for that use.
• Interactions: Alcohol, other sedatives and medicines that prolong QT or affect dopamine pathways may increase risk.
• Other cautions: Pregnancy, breastfeeding, seizure disorders, glaucoma, liver disease and use in children require individual assessment. Seek urgent care for severe muscle stiffness, high fever, abnormal movements or fainting.

10. Storage Instructions

Store according to the approved pack label, in original packaging and protected from light and unsuitable moisture or heat. Keep out of reach of children. The precise storage temperature and shelf life must be confirmed from the registered product information.

Important: Professional product information only, not individualized medical advice. Manufacturer certifications, export credentials, processes and additional formulations require verification.